Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Elevance Health Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents 7,866 6,497 6,226 6,526 10,919 9,991 10,142 7,387 8,872 6,456 6,161 4,880 5,490 5,258 9,326 5,741 3,984 6,028 5,345 4,937 4,190 4,078 4,482
Fixed maturity securities 28,954 28,900 29,530 29,614 27,811 28,021 27,636 25,952 25,526 25,765 26,219 26,267 26,348 25,848 24,555 23,433 22,707 22,018 19,881 19,676 19,960 19,123 17,795
Equity securities 1,113 594 511 229 165 272 392 953 1,503 1,572 1,662 1,881 2,119 1,746 3,630 1,559 3,075 3,470 570 1,009 2,300 1,492 1,211
Premium receivables 7,209 8,040 8,931 7,902 7,883 7,431 8,246 7,083 6,682 6,757 7,349 5,681 6,008 5,834 6,111 5,279 5,343 5,456 5,786 5,173 4,782 4,751 5,049
Self-funded receivables 5,135 5,297 4,242 4,558 3,756 3,896 3,786 4,663 3,873 3,844 3,979 4,010 3,349 3,605 3,109 2,849 2,985 2,460 2,613 2,411 2,555 2,534 2,491
Other receivables 6,055 5,881 5,120 5,405 5,293 5,196 4,678 4,298 3,651 3,600 3,334 3,749 3,450 3,246 3,071 2,830 3,209 3,072 2,926 2,807 3,038 2,801 2,800
Other current assets 5,949 6,464 6,388 5,795 5,358 4,936 4,943 5,281 5,496 5,661 5,193 4,654 5,140 4,701 4,693 4,060 4,147 4,260 4,135 3,020 2,679 3,026 2,783
Assets held for sale 565 601
Current assets 62,846 62,274 60,948 60,029 61,185 59,743 59,823 55,617 55,603 53,655 53,897 51,122 51,904 50,238 54,495 45,751 45,450 46,764 41,256 39,033 39,504 37,805 36,611
Fixed maturity securities 893 849 880 876 816 775 783 752 622 603 596 632 625 581 558 562 558 520 505 505 518 509 492
Other invested assets 9,394 6,810 6,713 6,107 6,118 5,993 5,971 5,685 5,516 5,398 5,365 5,225 4,959 4,917 4,474 4,285 4,170 4,097 4,181 4,258 3,943 3,752 3,743
Long-term investments 10,287 7,659 7,593 6,983 6,934 6,768 6,754 6,437 6,138 6,001 5,961 5,857 5,584 5,498 5,032 4,847 4,728 4,617 4,686 4,763 4,461 4,261 4,235
Property and equipment, net 4,505 4,450 4,451 4,359 4,248 4,547 4,418 4,316 4,197 4,090 3,986 3,919 3,835 3,733 3,533 3,483 3,363 3,427 3,350 3,133 2,921 2,837 2,799
Goodwill 25,967 25,962 25,947 25,317 25,291 25,274 25,273 24,383 24,381 24,367 24,251 24,228 24,184 24,399 21,708 21,691 21,687 21,641 21,661 20,500 20,500 20,500 20,500
Other intangible assets 10,325 10,447 10,710 10,273 10,491 10,703 10,915 10,315 10,536 10,762 10,588 10,615 10,749 10,540 9,352 9,405 9,497 9,577 9,613 8,674 8,756 8,840 8,925
Other noncurrent assets 2,603 2,196 2,245 1,967 2,329 2,133 1,857 1,704 2,171 2,002 1,803 1,719 1,804 1,689 1,563 1,438 1,849 1,950 1,833 1,350 1,667 1,608 1,453
Noncurrent assets 53,687 50,714 50,946 48,899 49,293 49,425 49,217 47,155 47,423 47,222 46,589 46,338 46,156 45,859 41,188 40,864 41,124 41,212 41,143 38,420 38,305 38,046 37,912
Total assets 116,533 112,988 111,894 108,928 110,478 109,168 109,040 102,772 103,026 100,877 100,486 97,460 98,060 96,097 95,683 86,615 86,574 87,976 82,399 77,453 77,809 75,851 74,523

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Assets: Selected Items

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Elevance Health Inc. current assets increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Elevance Health Inc. property and equipment, net decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 exceeding Q1 2024 level.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Elevance Health Inc. noncurrent assets decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 exceeding Q1 2024 level.
Total assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Elevance Health Inc. total assets increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.

Current Assets: Selected Items

Balance sheet item Description The company
Cash and cash equivalents Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Elevance Health Inc. cash and cash equivalents increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.